Compounds for targeted protein degradation
OwnerDavid MCGARRY, Gregor MEIER +5inventors
InventorsDavid MCGARRY, Gregor MEIER, James OSBORNE, Andrea TESTA, Giles Albert BROWN, Martin AMBLER, Charlene FALLAN
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a novel class of bifunctional molecules that are useful in a targeted or selective degradation of a protein.
Claims33
A bifunctional molecule comprising the general formula:
- TBL-L-Z
- wherein TBL is a target protein binding ligand that binds BRD9;
- L is a linker;
- and
- Z comprises a structure according to formula (I):
- wherein
- R1 is selected from C1 to C6 alkyl, benzyl, substituted benzyl, carbocyclyl, substituted carbocyclyl, heterocyclyl and substituted heterocyclyl, optionally wherein the C1 to C6 alkyl is substituted with one or more heteroatoms selected from halo, N, O and S and/or is substituted with a carbocyclic or heterocyclic group;
- A is absent or is CR2R2′;
- B is selected from aryl, heteroaryl, substituted aryl and substituted heteroaryl;
- R2 and R2′ are each independently selected from H and C1 to C6 alkyl, optionally wherein the C1 to C6 alkyl is substituted with one or more heteroatoms selected from halo, N, O or S, or wherein R2 and R2′ together form a 3-, 4-, 5- or 6-membered carbocyclic or heterocyclic ring;
- R3 is selected from C1-C6 alkyl, cycloalkyl, substituted cycloalkyl, alkylcycloalkyl, substituted alkylcycloalkyl, heterocycloalkyl, substituted heterocycloalkyl, alkyl heterocycloalkyl, substituted alkylheterocycloalkyl, aryl, substituted aryl, alkyl aryl, substituted alkylaryl, heteroaryl, substituted heteroaryl, alkyl heteroaryl, substituted alkylheteroaryl, optionally wherein the C1-C6 alkyl is substituted with one or more heteroatoms selected from halo, N, O and S;
- R4 is H, C1 to C6 alkyl, optionally wherein the C1 to C6 alkyl is substituted with one or more heteroatoms selected from N, O or S;
- or wherein R1 and R4 together form a 5-, 6-, or 7-membered heterocyclic ring;
- or wherein when A is CR2R2′:
- R1 and R2 together form a 5-, 6-, or 7-membered heterocyclic ring;
- or
- R2 and R4 together form a 5-, 6-, or 7-membered heterocyclic or carbocyclic ring;
- wherein L shows the point of attachment of the linker;
- and
- wherein the BRD9 binder (TBL) is of formula 1a:
- wherein:
- Z1 is N or CRA;
- Z2 is N or CRB;
- Z3 is N or CRD;
- Z4 is N or CRE;
- wherein no more than 3 of Z1, Z2, Z3 and Z4 are N;
- RA and RE are each independently selected from the group consisting of —H, —O—C1-3alkyl and —C1-3alkyl;
- RB and RD are each independently selected from the group consisting of —O—C1-3alkyl, —H, —OH, halogen, —NH2, —C1-3alkyl, —O—C1-3haloalkyl, —C1-3alkyl-O—C1-3alkyl, 4-7 membered heterocycloalkyl, —C1-3alkyl-SO2—C1-3alkyl, —C1-3alkyl-NH2, —C1-3alkyl-N(—C1-3alkyl)2, —N(C1-3 alkyl)2, —NH—RF;
- RF is selected from —SO2—C1-3alkyl and —C1-3alkyl, wherein the —C1-3alkyl is optionally substituted with a 5 to 6 membered heteroaryl;
- alternatively, RA and RB taken together form a benzene ring;
- alternatively, RC and Z2 or RC and Z3 taken together form a 5-7 membered heterocycloalkyl optionally substituted with —C1-3alkyl;
- RC is selected from the group consisting of —H, —Y—RG, —NH2, —C1-3alkyl and 4-7 membered heterocycloalkyl;
- Y is absent or is selected from the group consisting of —CRHRI—, —SO2— and —CO—;
- RH and RI are each independently selected from —H or —C1-3alkyl;
- or RH and RI taken together form a —C3-4cycloalkyl,
- RG is selected from the group consisting of —NH2, —OH, —C1-3alkyl, —N(RJRK), —O—RL, aryl, 5-6 membered heteroaryl, wherein the aryl and heteroaryl are optionally and independently substituted with one or more halogen, optionally substituted 4- to 7-membered monocyclic heterocycloalkyl, and optionally substituted 7- to 12-membered bicyclic heterocycloalkyl, which monocyclic or bicyclic heterocycloalkyl are optionally substituted with one or more groups independently selected from halogen, —OH, —NH2, —C1-3alkyl, —NHC1-3alkyl, —N(C1-3alkyl)2, —O—C1-3alkyl and —CH2—RM1;
- RM1 is selected from 5-10 membered mono- or bicyclic aryl or heteroaryl, which is optionally substituted with —NH2, —OH, halogen, —CN, C1-3alkyl, —O—C1-3alkyl;
- RJ is —H or —C1-3alkyl;
- RK is selected from the group consisting of —C1-3alkyl, —C2-3alkyl-N(C1-3alkyl)2, —C2-3alkyl-NHC1-3alkyl, optionally substituted 4- to 7-membered monocyclic heterocycloalkyl, and optionally substituted 7- to 12-membered bicyclic heterocycloalkyl, which monocyclic or bicyclic heterocycloalkyl is optionally substituted with —C1-3alkyl;
- RL is —C1-3alkyl or a 4-7 membered heterocycloalkyl, which heterocycloalkyl is optionally substituted with C1-3alkyl;
- wherein when RC is Y—RG, RB and RD are each independently selected from —H, —OH, halogen, —NH2, —CN, —C1-3alkyl, —C1-3haloalkyl, —O—C1-3alkyl, —O—C1-3haloalkyl and —C1-3alkyl-O—C1-3alkyl;
- wherein at least one of the substituents RA to RE is not hydrogen;
- and
- A2 is selected from formulae 1b or 1c:
- wherein the wavy fines intersect the bond between A2 and the carbon atom positioned ortho to RA and RE;
- RM is selected from the group consisting of optionally substituted C1-6alkyl, optionally substituted C2-6alkenyl, optionally substituted C1-6heteroalkyl, optionally substituted C3-10carbocyclyl, C2-6alkynyl and H;
- Z5 is N or CRO;
- Z is N or CRP;
- Z7 is N or CRN;
- wherein only one of Z5, Z6 and Z7 is N;
- Z8 is CRW or N;
- RN is selected from the group consisting of halogen, optionally substituted —C1-6alkyl, —H, C(O)C1-5alkyl, —NH2, optionally substituted amino, —OH, cyano, optionally substituted C1-6heteroalkyl, optionally substituted C3-10 carbocyclyl, optionally substituted C2-9heterocyclyl, optionally substituted C6-10aryl, optionally substituted C2-9heteroaryl, optionally substituted C2-6alkenyl, optionally substituted C2-6heteroalkenyl and thiol;
- RO is selected from the group consisting of H, halogen, cyano, optionally substituted C1-6alkyl, optionally substituted C1-6heteroalkyl, optionally substituted C3-10carbocyclyl, optionally substituted C2-9heterocyclyl, optionally substituted C6-10aryl, optionally substituted C2-9heteroaryl, optionally substituted C2-6alkenyl, optionally substituted C2-6heteroalkenyl, hydroxy, thiol and optionally substituted amino;
- RP is selected from the group consisting of H, halogen, optionally substituted C1-6alkyl, optionally substituted C1-6heteroalkyl, optionally substituted C3-10carbocyclyl and optionally substituted C6-10aryl;
- alternatively, RN and Z5 taken together, combine to form an optionally substituted C6-10arene or optionally substituted C2-9heteroarene;
- optionally wherein RN and RO taken together with the carbon atoms to which they are joined, combine to form an optionally substituted C6-10arene or optionally substituted C2-9heteroarene;
- RS is selected from the group consisting of H, optionally substituted C1-6alkyl, optionally substituted C1-6heteroalkyl and optionally substituted C3-10carbocyclyl;
- RT is selected from the group consisting of H, optionally substituted C1-6alkyl, optionally substituted C1-6heteroalkyl, optionally substituted C3-10carbocyclyl, optionally substituted C2-9heterocyclyl, optionally substituted C6-10aryl, optionally substituted C2-9heteroaryl, optionally substituted C2-6alkenyl, optionally substituted C2-6heteroalkenyl, optionally substituted sulfone and optionally substituted sulfonamide, or RT and RU together with the atoms to which each is attached, form an optionally substituted C2-9heterocyclyl;
- RU and RV are each independently selected from the group consisting of H, halogen, hydroxyl, optionally substituted C1-6alkyl, optionally substituted C1-6heteroalkyl, optionally substituted C3-10carbocyclyl, optionally substituted C2-9heterocyclyl, optionally substituted C6-10aryl, optionally substituted C2-9heteroaryl, optionally substituted C2-6alkenyl, optionally substituted C2-6heteroalkenyl, thiol, optionally substituted sulfone and optionally substituted amino;
- alternatively, RT and RU together with the atoms to which each is attached, form an optionally substituted C2-9heterocyclyl;
- RW is selected from the group consisting of H, halogen, optionally substituted C1-6alkyl, optionally substituted C1-6heteroalkyl, optionally substituted C3-10carbocyclyl, optionally substituted C2-9heterocyclyl, optionally substituted C6-10aryl and optionally substituted C2-9heteroaryl;
- and
- wherein the BRD9 binder is attached to the linker at any suitable position;
- and
- (iii) wherein the bifunctional molecule is not:
The bifunctional molecule according to any one of the preceding claims, wherein R3 is selected from the group consisting of a heteroaryl, substituted heteroaryl, C1-C6 alkyl, C3-C6 cycloalkyl, C3-C6 cycloheteroalkyl, C1-C6 alkyl substituted with a heterocyclic group, aryl, and substituted aryl,
- optionally wherein R3 is selected from:
- wherein the dotted line indicates the position at which each of the respective R3 groups is joined to the structure shown in formula (I) to (Ic), or wherein when the dotted line is not appended to an atom, the dotted line indicates that each of the respective R3 groups is joined to the structure via any position on the aromatic or heteroaromatic ring;
- each R5 is independently selected from the group consisting of halo, CH2OH, CF3, —CH2F, —CHF2, OCF3, —OCH2F, —OCHF2, C1 to C6 alkyl, —CN, —OH, —OMe, —SMe, —SOMe, —SO2Me, —NH2, —NHMe, —NMe2, CO2Me, —NO2, CHO and COMe;
- n is 0 to 3;
- R6 is C1 to C6 alkyl;
- G is CH2, O and NH;
- and
- Q is C1 to C6 alkylene.
The bifunctional molecule according to any one of the preceding claims, wherein A is CR2R2′, optionally wherein:
- (i) one of R2 and R2′ is a hydrogen and the other is C1 to C6 alkyl, optionally wherein the C1 to C6 alkyl is substituted with one or more halo atoms;
- or (ii) both of R2 and R2′ are selected from C1 to C6 alkyl.
The bifunctional molecule according to any one of the preceding claims, wherein Z is represented as formula (IIaa):
- wherein A, R3, and L are as defined for formula (I);
- n is 1, 2 or 3;
- and
- W is selected from CRW1RW2, O, NRW3 and S;
- and
- RW1, RW2 and RW3 are each independently selected from H and C1 to C6 alkyl;
- and
- wherein when n is 2 or 3, each W is independently selected from CRW1RW2, O, NRW3, and S;
- optionally wherein:
- (i) Z is represented as formula (IIa):
- wherein R2, R2′, R3 and L are as defined in any one of the preceding claims,
- n is 1, 2 or 3;
- and
- W is selected from CRW1RW2, O, NRW3 and S;
- and
- RW1, RW2 and RW3 are each independently selected from H and C1 to C6 alkyl;
- and
- wherein when n is 2 or 3, each W is independently selected from CRW1RW2, O, NRW3, and S.
The bifunctional molecule according to any one of the preceding claims, wherein the linker comprises 1 to 25 or 1 to 18 atoms in a single linear chain.
The bifunctional molecule according to any one of the preceding claims, wherein linker comprises 1 to 10 or 1 to 8 rotatable bonds.
The bifunctional molecule according to any one of the preceding claims, wherein the linker (L) is a covalent bond or the structure of the linker (L) is:
- (Lx)q
- wherein each Lx represents a subunit of L that is independently selected from CRL1RL2, O, C═O, S, SO, SO2, NRL3, SONRL4, SONRL5C═O, CONRL6, NRL7CO, C(RL8)═C(RL9), C≡C, aryl, substituted aryl, heteroaryl, substituted heteroaryl, carbocyclyl, substituted carbocyclyl, heterocyclyl and substituted heterocyclyl groups;
- wherein RL1, RL2, RL3, RL4, RL5, RL6, RL7, RL8 and RL9 are each independently selected from H, halo, C1 to C6 alkyl, C1 to C6, haloalkyl, —OH, —O(C1 to C6 alkyl), —NH2, —NH(C1 to C6 alkyl), —NO2, —CN, —CONH2, —CONH(C1 to C6 alkyl), —CON(C1 to C6 alkyl)2, —SO2(C1 to C6 alkyl), —CO2(C1 to C6 alkyl), and —CO(C1 to C6 alkyl);
- and
- q is an integer between 1 and 30.
The bifunctional molecule according to any one of the preceding claims, wherein the bifunctional molecule has a structure as shown in Table 1.
A pharmaceutical composition comprising the bifunctional molecule according to any one of the preceding claims, together with a pharmaceutically acceptable carrier, optionally wherein the bifunctional molecule is present in the composition as a pharmaceutically acceptable salt, solvate or derivative.
Dependencies are inferred from the claim text.